BDBM497327 US11001595, Compound 1::US11001595, Compound 5::US11111252, Compound 1

SMILES COc1ccc(Sc2sc3nc(N)nc(N)c3c2C)cc1OC

InChI Key InChIKey=YOJLXUCTDDKMGX-UHFFFAOYSA-N

Data  16 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 16 hits for monomerid = 497327   

TargetDihydrofolate reductase(Human pneumocystis pneumonia agent)
Duquesne University of The Holy Spirit

US Patent
LigandPNGBDBM497327(US11111252, Compound 1 | US11001595, Compound 5 | ...)
Affinity DataIC50: 260nMAssay Description:Table 7: The inhibitory activities of TMP and TMQ are listed for comparison. While the tested compounds displayed reduced potency against pjDHFR comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2022
Entry Details
Go to US Patent

TargetDihydrofolate reductase(Human)
Duquesne University of The Holy Spirit

US Patent
LigandPNGBDBM497327(US11111252, Compound 1 | US11001595, Compound 5 | ...)
Affinity DataIC50: 910nMAssay Description:Table 7: The inhibitory activities of TMP and TMQ are listed for comparison. While the tested compounds displayed reduced potency against pjDHFR comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2022
Entry Details
Go to US Patent

TargetDihydrofolate reductase(Human pneumocystis pneumonia agent)
Duquesne University of The Holy Spirit

US Patent
LigandPNGBDBM497327(US11111252, Compound 1 | US11001595, Compound 5 | ...)
Affinity DataIC50: 3.90E+3nMAssay Description:Table 7: The inhibitory activities of TMP and TMQ are listed for comparison. While the tested compounds displayed reduced potency against pjDHFR comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2022
Entry Details
Go to US Patent

TargetDihydrofolate reductase(Human)
Duquesne University of The Holy Spirit

US Patent
LigandPNGBDBM497327(US11111252, Compound 1 | US11001595, Compound 5 | ...)
Affinity DataIC50: 6.90E+3nMAssay Description:Table 7: The inhibitory activities of TMP and TMQ are listed for comparison. While the tested compounds displayed reduced potency against pjDHFR comp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor(Human)
Duquesne University of The Holy Spirit

US Patent
LigandPNGBDBM497327(US11111252, Compound 1 | US11001595, Compound 5 | ...)
Affinity DataIC50: 1.51E+4nMAssay Description:Table 9: Compounds 1 and 2, Section D., (see FIG. 4, bottom row, far right column) each inhibit VEGFR-2 and PDGFR-β for antiangiogenic effects a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2022
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Duquesne University of The Holy Spirit

US Patent
LigandPNGBDBM497327(US11111252, Compound 1 | US11001595, Compound 5 | ...)
Affinity DataIC50: 2.26E+4nMAssay Description:Table 9: Compounds 1 and 2, Section D., (see FIG. 4, bottom row, far right column) each inhibit VEGFR-2 and PDGFR-β for antiangiogenic effects a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2022
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 1(Human)
Duquesne University of The Holy Spirit

US Patent
LigandPNGBDBM497327(US11111252, Compound 1 | US11001595, Compound 5 | ...)
Affinity DataIC50: 1.18E+5nMAssay Description:Table 9: Compounds 1 and 2, Section D., (see FIG. 4, bottom row, far right column) each inhibit VEGFR-2 and PDGFR-β for antiangiogenic effects a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2022
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Duquesne University of The Holy Spirit

US Patent
LigandPNGBDBM497327(US11111252, Compound 1 | US11001595, Compound 5 | ...)
Affinity DataIC50: 2.80E+3nMAssay Description:Table 9: Compounds 1 and 2, Section D., (see FIG. 4, bottom row, far right column) each inhibit VEGFR-2 and PDGFR-β for antiangiogenic effects a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2022
Entry Details
Go to US Patent

TargetDihydrofolate reductase(Human pneumocystis pneumonia agent)
Duquesne University of The Holy Spirit

US Patent
LigandPNGBDBM497327(US11111252, Compound 1 | US11001595, Compound 5 | ...)
Affinity DataIC50: 260nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
Go to US Patent

TargetDihydrofolate reductase(Human)
Duquesne University of The Holy Spirit

US Patent
LigandPNGBDBM497327(US11111252, Compound 1 | US11001595, Compound 5 | ...)
Affinity DataIC50: 910nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
Go to US Patent

TargetDihydrofolate reductase(Human pneumocystis pneumonia agent)
Duquesne University of The Holy Spirit

US Patent
LigandPNGBDBM497327(US11111252, Compound 1 | US11001595, Compound 5 | ...)
Affinity DataIC50: 3.90E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
Go to US Patent

TargetDihydrofolate reductase(Human)
Duquesne University of The Holy Spirit

US Patent
LigandPNGBDBM497327(US11111252, Compound 1 | US11001595, Compound 5 | ...)
Affinity DataIC50: 6.90E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor(Human)
Duquesne University of The Holy Spirit

US Patent
LigandPNGBDBM497327(US11111252, Compound 1 | US11001595, Compound 5 | ...)
Affinity DataIC50: 1.51E+4nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Duquesne University of The Holy Spirit

US Patent
LigandPNGBDBM497327(US11111252, Compound 1 | US11001595, Compound 5 | ...)
Affinity DataIC50: 2.26E+4nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 1(Human)
Duquesne University of The Holy Spirit

US Patent
LigandPNGBDBM497327(US11111252, Compound 1 | US11001595, Compound 5 | ...)
Affinity DataIC50: 1.18E+5nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Duquesne University of The Holy Spirit

US Patent
LigandPNGBDBM497327(US11111252, Compound 1 | US11001595, Compound 5 | ...)
Affinity DataIC50: 2.80E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2021
Entry Details
Go to US Patent